Literature DB >> 16833175

Intravitreal triamcinolone acetonide for diabetic macula edema.

Anat Loewenstein, Michaella Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16833175

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  6 in total

1.  Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1).

Authors:  R Mathew; E Pearce; R Muniraju; A Abdel-Hay; A Abdul-Hey; S Sivaprasad
Journal:  Eye (Lond)       Date:  2014-01-03       Impact factor: 3.775

Review 2.  Treatment of Diabetic Macular Edema.

Authors:  Eric J Kim; Weijie V Lin; Sean M Rodriguez; Ariel Chen; Asad Loya; Christina Y Weng
Journal:  Curr Diab Rep       Date:  2019-07-29       Impact factor: 4.810

Review 3.  Meta-analysis and review on the effect of bevacizumab in diabetic macular edema.

Authors:  Sunali Goyal; Michael Lavalley; Manju L Subramanian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-28       Impact factor: 3.117

4.  Cystoid macular edema.

Authors:  Tryfon G Rotsos; Marilita M Moschos
Journal:  Clin Ophthalmol       Date:  2008-12

5.  Visual outcome of laser treatment in diabetic macular edema: Study from an Urban Diabetes Care Center.

Authors:  Rashid Alvi; Muhammad Saleh Memon; Samad Shera; Seema N Mumtaz; Sikander Ali Shaikh; Muhammad Faisal Fahim
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

6.  Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.

Authors:  Ahmed Abdel-Hay; Sobha Sivaprasad; Ahalya Subramanian; John L Barbur
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.